Quick Takeaways: Why It Matters? The FDA’s EUA for generic Nitenpyram Tablets creates an immediate, affordable, OTC treatment option for pet owners facing necrotizing worm (NWS) fly infestations in dogs, puppies, cats, and kittens ≥2 lb and ≥4 weeks old. This broadens access to a cost...
Quick Takeaways: Why It Matters? Unlike drugs that carry safety concerns or diminishing effectiveness, LIFU aims to provide a non-invasive alternative to nerve blocks and radiofrequency ablation without systemic exposure, which could reduce reliance on medications and invasive procedures. ...
Quick Takeaways: Why It Matters? At scale (100,000+ ER visits already), AI-assisted documentation can meaningfully cut admin time, speed chart closure, and let vets and scribes reallocate hours to procedures, decision‑making, and client communication, helping VEG differentiate ...
Quick Takeaways: Why It Matters? Cronus Pharma is bringing price competition to a key canine heart failure drug class by launching the first FDA‑approved bioequivalent chewable to Vetmedin, available nationwide through vet distributors. For the market, this should lo...
Quick Takeaways: Why It Matters? Viyash is using BioForLife as a front-end platform to scale its companion animal business in Europe, starting with Italy, one of the continent’s largest and fastest-growing pet health markets. Market-wise, the all-cash ...
Quick Takeaways: Why It Matters? This deal gives Merck Animal Health an early, exclusive window into a gene-therapy pipeline for chronic and age-related diseases in pets, while Rejuvenate Bio secures non-dilutive R&D support and a $6M financing round to advance its platform...
Quick Takeaways: Why It Matters? VetrixBio is testing a dual-action osteoarthritis therapy that targets both pain (NGF/TrkA) and cartilage degradation (ADAMTS-5) in dogs, rather than just providing analgesia. The clinical data in aged Beagles shows a single...
Quick Takeaways Why It Matters? Parnell strengthens its position in the controlled veterinary injectables segment, gaining preference among practices prioritizing safety-differentiated euthanasia agents. Visual dye innovation reduces medication errors, accelerating adopti...
Quick Takeaways: Why It Matters? Cosmos Health is using its established human healthcare brand C-Scrub to cross into the UK veterinary market with a 4% chlorhexidine antimicrobial wash that independently meets key European veterinary disinfectant standards. The market imp...
Quick Takeaways: Why It Matters? This deal is about scaling continuous infection-control tech into mainstream animal-health settings, not just adding another equipment line. By plugging Synexis DHP into Midwest Veterinary Supply’s national network, cli...
